Skip to main content
Premium Trial:

Request an Annual Quote

Definiens Places New Tissue Array Analysis Platform at Karmanos Cancer Institute


By Justin Petrone

Definiens this week announced that scientists at the Barbara Ann Karmanos Cancer Institute in Detroit will use its tissue microarray image analysis software in their cancer-diagnosis and biomarker-development projects.

The Karmanos Cancer Institute will use Definiens' Tissue Studio 2.0 digital pathology software to automate tissue section and microarray analysis. Researchers at the institute "aim to improve the speed and accuracy of diagnosis by automating image analysis of tissue sections stained for morphology and biomarker expression, as well as tissue microarrays measuring clinically relevant biomarkers," according to Munich-based Definiens.

Thomas Colarusso, vice president of Definiens' North American sales and operations, told BioArray News that the newly launched software provides "full tissue microarray support, for both bright field and immunofluorescent images, and supports metadata import on a per-core basis."

He said that Definiens' software can be used to "look for correlations between biomarker expression, tumor morphology, and clinical endpoints of interest."

Gerold Bepler, president and CEO of the Karmanos Institute, said in a statement that the institute will use Tissue Studio to analyze cancers, including lung, breast, and pancreatic cancer, on the cellular and sub-cellular level.

"Automating image analysis in our research will significantly enhance our ability to apply knowledge of cancer characteristics to patient diagnosis and treatment," Bepler said. "The software will help us classify tumors and generate better prognostic and predictive data. We expect this will improve our ability to stratify patients for the most promising clinical approach."

Financial terms of the deal were not discussed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.